In a groundbreaking achievement, Health Reactive has proudly become India’s 1st company to conduct human clinical trials in Ayurveda. Spearheaded by Mr. Munish Khan, CEO of Health Reactive, this futuristic step has placed India at the forefront of integrating ancient Ayurvedic wisdom with modern scientific validation. The clinical trial on Body Revival, an Ayurvedic liquid suspension, marks a monumental milestone, making it the first-ever in India to scientifically validate Ayurveda’s potential in supporting breast cancer care.

The clinical trial, conducted in J.B. Roy State Ayurvedic Medical College & Hospital - Dept. of Health & Family Welfare (AYUSH), Govt. of W.B. The West Bengal University of Health Sciences (Affiliated), focused on post-surgery breast cancer patients undergoing chemotherapy and radiotherapy. The randomized, case-control study lasted starting from 1^st October 2023 to 30^th November 2024 and included 44 participants. It aimed to evaluate Body Revival's ability to improve quality of life (QoL) and progression-free survival (PFS), while also counteracting the adverse side effects of chemotherapy and radiotherapy.